Ftse Mib
33.336,13
0,45%
DAX
18.329,56
0,68%
S&P 500
5.482,87
0,09%
NASDAQ
17.858,68
0,30%
Bitcoin
61.529,75
-0,13%
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Germania TG Genmab AS (GE9) Genmab AS (GE9) Notizie

Genmab AS

GE9
236,20
-2,40 (-1,01%)
13:15:20 - Dati in Tempo Reale
Borsa: Tradegate
Tipo: Azione Ordinaria
Valuta: EUR

Ultime notizie

Data Ora Fonte Titolo
28/6/202408:00GLOBEEpcoritamab (TEPKINLY®) Receives Positive CHMP Opinion for..
27/6/202423:00GLOBECompletion of Share Buy-back Program
27/6/202401:03GLOBEEPKINLY® (epcoritamab-bysp) Approved by U.S. FDA for..
24/6/202415:55GLOBETransactions in Connection with Share Buy-back Program
18/6/202420:45GLOBECapital Increase in Genmab as a Result of Employee Warrant..
17/6/202415:33GLOBETransactions in Connection with Share Buy-back Program
12/6/202421:45GLOBEGrant of Restricted Stock Units and Warrants to Employees in..
11/6/202420:50GLOBETransactions with shares and linked securities in Genmab A/S..
10/6/202416:18GLOBETransactions in Connection with Share Buy-back Program
05/6/202418:51GLOBEGenmab to Participate in a Fireside Chat at the Goldman..
03/6/202415:09GLOBETransactions in Connection with Share Buy-back Program
03/6/202415:00GLOBEInvestigational Tisotumab Vedotin Phase 2 Data Demonstrates..
02/6/202423:30GLOBEPreliminary Analysis of Data Evaluating Investigational..
01/6/202416:00GLOBEInvestigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in..
27/5/202416:16GLOBETransactions in Connection with Share Buy-back Program
23/5/202423:00GLOBEGenmab to Showcase Data in Various Patient Populations to be..
21/5/202417:06GLOBEGenmab Completes Acquisition of ProfoundBio
21/5/202413:19GLOBETransactions in Connection with Share Buy-back Program
14/5/202416:02GLOBEGenmab to Present New and Updated Results From Multiple..
13/5/202416:09GLOBETransactions in Connection with Share Buy-back Program
07/5/202420:27GLOBECapital Increase in Genmab as a Result of Employee Warrant..
06/5/202416:01GLOBETransactions in Connection with Share Buy-back Program
02/5/202417:01GLOBEGenmab Announces Financial Results for the First Quarter of..
30/4/202400:40GLOBETIVDAK® (tisotumab vedotin-tftv) Receives U.S. FDA Approval..
29/4/202410:24GLOBETransactions in Connection with Share Buy-back Program..
22/4/202409:30GLOBETransactions in Connection with Share Buy-back Program..
16/4/202412:24GLOBEGenmab Announces Net Sales of DARZALEX® (daratumumab) for..
15/4/202410:07GLOBETransactions in Connection with Share Buy-back Program..
08/4/202411:44GLOBETransactions in Connection with Share Buy-back Program
03/4/202407:34GLOBEGenmab to Broaden and Strengthen Oncology Portfolio with..
02/4/202409:24GLOBETransactions in Connection with Share Buy-back Program
25/3/202414:30GLOBETransactions in Connection with Share Buy-back Program
18/3/202410:49GLOBECompletion of share buy-back program
15/3/202413:16GLOBEGenmab Announces Initiation of Share Buy-Back Program
13/3/202421:58GLOBETransactions with shares and linked securities in Genmab A/S..
13/3/202421:52GLOBEConstitution of the Board of Directors in Genmab A/S, Grant..
13/3/202416:13GLOBEPassing of Genmab A/S’ Annual General Meeting
11/3/202410:42GLOBETransactions in connection with share buy-back program
04/3/202419:10GLOBETransactions with shares and linked securities in Genmab A/S..
04/3/202410:29GLOBETransactions in connection with share buy-back program
02/3/202400:04GLOBETransactions with shares and linked securities in Genmab A/S..
29/2/202416:48GLOBETransactions with shares and linked securities in Genmab A/S..
27/2/202421:42GLOBETransactions with shares and linked securities in Genmab A/S..
27/2/202421:40GLOBECapital Increase in Genmab as a Result of Employee Warrant..
27/2/202401:45GLOBEU.S. FDA Accepts for Priority Review the Supplemental..
26/2/202411:21GLOBETransactions in connection with share buy-back program
23/2/202423:50GLOBETransactions with shares and linked securities in Genmab A/S..
23/2/202423:35GLOBEGrant of Restricted Stock Units to Management and Employees..
19/2/202410:40GLOBETransactions in connection with share buy-back program
15/2/202412:00GLOBENotice to Convene the Annual General Meeting of Genmab A/S
Apertura: 239,50 Min: 236,20 Max: 239,50
Chiusura: 238,60

La tua Cronologia

TG
GE9
Genmab AS
BIT
P204B1
NLBNPIT204B1 20991231 18...
BIT
UV4KDG
Unicredit Bank
BIT
P1ORJ7
BNP Paribas Issuance
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network